Cargando…

Clozapine resistant schizophrenia: Newer avenues of management

About 40%-70% of the patients with treatment-resistant schizophrenia have a poor response to adequate treatment with clozapine. The impact of clozapine-resistant schizophrenia (CRS) is even greater than that of treatment resistance in terms of severe and persistent symptoms, relapses and hospitaliza...

Descripción completa

Detalles Bibliográficos
Autor principal:	Chakrabarti, Subho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394694/ https://www.ncbi.nlm.nih.gov/pubmed/34513606 http://dx.doi.org/10.5498/wjp.v11.i8.429

Ejemplares similares

Starting clozapine in patients with schizophrenia during the ongoing pandemic
por: Grover, Sandeep, et al.
Publicado: (2022)

Newer Avenues in IJA academics
por: Joshi, Muralidhar
Publicado: (2020)

Impact of clozapine on disability and course of illness in patients with schizophrenia: A study from North India
por: Grover, Sandeep, et al.
Publicado: (2021)

Dropout Rates And Reasons For Dropout In Patients On Clozapine
por: Mishra, Eepsita, et al.
Publicado: (2022)

Management of patients with Clozapine Resistant Schizophrenia
por: Rajendran*, Nithya Ragavi, et al.
Publicado: (2022)

Dropout rates and reasons for dropout among patients receiving clozapine
por: Grover, Sandeep, et al.
Publicado: (2023)

Metabolic Disturbances, Side Effect Profile and Effectiveness of Clozapine in Adolescents
por: Grover, Sandeep, et al.
Publicado: (2016)

Newer advances in medical management of glaucoma
por: Mohan, Neethu, et al.
Publicado: (2022)

Metabolic syndrome among patients receiving clozapine: A preliminary estimate
por: Grover, Sandeep, et al.
Publicado: (2011)

Eosinophilia Induced by Clozapine: A Report of Two Cases and Review of the Literature
por: Aneja, Jitender, et al.
Publicado: (2015)

Coping among the caregivers of patients with schizophrenia
por: Grover, Sandeep, et al.
Publicado: (2015)

Clinical Practice Guidelines for Management of Schizophrenia
por: Grover, Sandeep, et al.
Publicado: (2017)

Electroconvulsive therapy combined with clozapine in the management of ultra-resistant schizophrenia
por: Khouadja, S., et al.
Publicado: (2021)

Effectiveness of clozapine in treatment-resistant schizophrenia
por: Raguraman, Janakiraman, et al.
Publicado: (2005)

Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
por: Tseng, Ping-Tao, et al.
Publicado: (2022)

Religion, Spirituality, and Schizophrenia: A Review
por: Grover, Sandeep, et al.
Publicado: (2014)

Metabolic syndrome in schizophrenia
por: Malhotra, Nidhi, et al.
Publicado: (2013)

Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic
por: Grover, Sandeep, et al.
Publicado: (2020)

A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
por: Pang, Tiffanie Sze Wing, et al.
Publicado: (2023)

Managing Recurrent Clozapine-Induced Constipation in a Patient with Resistant Schizophrenia
por: Tomulescu, Silviu, et al.
Publicado: (2021)

Routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia
por: Kitchen, David, et al.
Publicado: (2022)

Clozapine is the approved option in treatment-resistant schizophrenia and requires careful management
por: Fenton, Caroline, et al.
Publicado: (2023)

A False Case of Clozapine-Resistant Schizophrenia
por: Maia-de-Oliveira, J. P., et al.
Publicado: (2010)

AN OPEN STUDY OF CLOZAPINE IN THE TREATMENT OF RESISTANT SCHIZOPHRENIA
por: Desai, Neena, et al.
Publicado: (1999)

Combination of ECT and clozapine in drug-resistant schizophrenia
por: Kurian, S., et al.
Publicado: (2005)

Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
por: Goldstein, Meghan Elizabeth, et al.
Publicado: (2015)

Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?
por: Montgomery, Adam, et al.
Publicado: (2023)

REFRACTORY SCHIZOPHRENIA, CLOZAPINE AND EPILEPSY : MANAGEMENT STRATEGIES
por: Guha, Prathama, et al.
Publicado: (1998)

Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
por: Qubad, Mishal, et al.
Publicado: (2023)

Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues…
por: Sharma, Ridhima, et al.
Publicado: (2021)

Clozapine prescribing barriers in the management of treatment-resistant schizophrenia: A systematic review
por: Baig, Anum Iqbal, et al.
Publicado: (2021)

RE: Routine clozapine assay monitoring to improve the management of treatment-resistant schizophrenia
por: Gupta, Sumeet, et al.
Publicado: (2023)

Effectiveness of Electroconvulsive Therapy Augmentation on Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2017)

Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia
por: Kim, Jung Hyun, et al.
Publicado: (2018)

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

Corrigendum to: Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
Publicado: (2023)

USE OF CLOZAPINE IN CHILDHOOD SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1997)

Successful Management of Patient with Treatment Resistant Schizophrenia and Swyer–James–Macleod Syndrome with Clozapine
por: Parmar, Arpit, et al.
Publicado: (2016)

A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
por: Correll, C. U., et al.
Publicado: (2022)

Religiosity among patients with schizophrenia: An exploratory study
por: Triveni, Davuluri, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ngsbji92dd79i11csccqs2jt6u